Cardiovascular research: New treatment potential for heart attack sufferers ♦ Heart failure improvements with diet and exercise ♦ When exercise is unhealthy for the heart:

Heart failure improvements with diet and exercise Doctors have shown the benefits of a healthy diet and exercise in patients with heart failure

First-in-human use of virtual reality imaging in cardiac cath lab to treat blocked coronary artery Virtual reality has potential to revolutionize some aspects of medicine and healthcare. Several medical specialties are already using it to train physicians and assist diagnosis and it also has potential for treatment. A group of cardiologists has now successfully used a VR device to guide the opening up (revascularization) of a chronically blocked right coronary artery.

When exercise is unhealthy for the heart: How heart problems and sudden cardiac death occur with endurance exercise Endurance exercise accelerates the development of heart problems in individuals with a particular genetic mutation, a new study finds. In mice with a mutated version of desmoplakin, a protein that maintains the heart wall, exercise made the heart walls come apart sooner. The findings offer insight into how to best manage exercise in individuals with the mutation.

New treatment potential for heart attack sufferers New hope in the fight against cardiovascular disease has arrived, following breakthrough research identifying a pigment in our bile which could protect us

Health Research: Gene-editing technique offers hope for hereditary diseases ♦ Non-alcoholic fatty liver disease ♦ TG1050, shows early signs of potential for chronic hepatitis B cure

Gene-editing technique offers hope for hereditary diseases Scientists have used molecular "scissors" to eliminate mitochondrial mutations in eggs and embryos. They are now investigating the possibility of translating this technology to the clinic in human eggs and embryos

Non-alcoholic fatty liver disease shown to affect the development of coronary artery calcification New data show that non-alcoholic fatty liver disease plays a role in the early stages of coronary atherosclerosis and in its more severe form it can also promote the development of coronary artery calcification.

Long-term therapy with ETV or TDF demonstrates positive 5-year survival in patients with chronic HBV Data show that the long-term use of entecavir or tenofovir results in excellent five-year survival for Caucasian patients with chronic hepatitis B, with more than 95 percent of patients surviving at five years and a significant proportion of deaths coming from liver-unrelated causes.

Novel immunotherapeutic, TG1050, shows early signs of potential for chronic hepatitis B cure A novel immunotherapeutic in early development for chronic hepatitis B , has been shown to reach the clinical goals that are considered to be the hallmarks of a cure for CHB.

Investigational anti-diabetic may offer potential for management of nonalcoholic fatty liver New research demonstrates that remogliflozin etabonate, an investigational drug in type 2 diabetes, is a potential treatment option for the management of patients with nonalcoholic steatohepatitis and non-alcoholic fatty liver disease.

UltraZx,weight loss suppliment recalled - it contained a cancer causing drug

UltraZx, Labs, L.L.C. is voluntarily recalling “UltraZx” weight loss supplements. This product has been found to contain undeclared Sibutramine and phenolphthalein.

FDA laboratory analysis of confirmed that UltraZx contains sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it presents a cancer causing risk. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Ultra ZX LABS, L.L.C. has not received any reports of adverse events related to this recall. UltraZx weight loss supplement is marketed as a dietary supplement used as a weight loss aid and is packaged in bottles of thirty (30) capsules of 300mg. The affected UltraZx weight loss supplement, includes all lots/bottles/packages. The products were distributed from September 2014 until February 2015.

UltraZx Labs, L.L.C. is notifying its distributors and customers by letter and is arranging for return of all recalled products. Consumers and distributors that have product which is being recalled should stop using the product and return the product to UltraZx Labs, L.L.C.

Consumers with questions regarding this recall can contact UltraZx Labs, L.L.C. at (305) 904-9393, Monday through Friday from 9:00am – 5:00pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

This recall is being conducted with the knowledge of the Food and Drug Administration (FDA).

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

Heart Health:Mediterranean diet cuts heart disease risk ♦ anger can trigger a heart attack! ♦ Eating Peanuts associated with decreased cardiovascular diseases ♦ Plus more

Mediterranean diet cuts heart disease risk by nearly half Adults who closely followed the Mediterranean diet were 47 percent less likely to develop heart disease over a 10-year period Continue Reading

Keep calm, anger can trigger a heart attack!  The risk of a heart attack is 8.5 times higher in the two hours following a burst of intense anger, researchers have found after investigating the link between acute emotional triggers and high risk of severe cardiac episodes Continue Reading

Homeless people with mental illness have higher 30-year risk of serious cardiovascular disease, research finds  Homeless people with mental disease have a greater than double risk of developing serious or fatal cardiovascular disease over 30 years than people of the same age and gender with no risk factors for the disease, Continue Reading

Peanut consumption associated with decreased total mortality from cardiovascular diseases  Researchers have examined the association of nut and peanut consumption with mortality among low-income and racially diverse populations and found that intake of peanuts was associated with fewer deaths from heart disease.Continue Reading

Excess sitting linked to coronary artery calcification, an early indicator of heart problems Sitting for many hours per day is associated with increased coronary artery calcification, a marker of subclinical heart disease that can increase the risk of a heart attack, according to research. Coronary artery disease is the leading cause of death in the United States.Continue Reading